Sign In
Buy CAR
$173.86
+1.48 (+0.86%)
At Close: Jun 03, 2026
CAR's Recovery Remains Weak After Extreme Volatility: Hold or Fold?
01:20pm, Monday, 18'th May 2026
CAR's pricing recovery and Waymo partnership offer long-term potential, but April's 70% stock collapse exposed major volatility risks.
Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune
10:46am, Thursday, 14'th May 2026
Cabaletta Bio, Inc. is reaffirmed as a Buy despite recent share price volatility, driven by tangible clinical and manufacturing progress. Key catalysts include registrational trials for rese-cel in my
SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the presentation of
Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models Data will be presented at the American Society of Gene & Cell Th
Multiple patients have survived substantially beyond expected median survival, including onepatient who survived 28 months and several patients who remain alive with continued follow-up Lira-cel clini
CAPREIT Reports First Quarter 2026 Results
05:00pm, Thursday, 07'th May 2026
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust ("CAPREIT
CAR Q1 Earnings Miss on Higher Fleet Charges, Revenues Beat
11:26am, Wednesday, 06'th May 2026
Avis Budget's Q1 loss misses estimates as fleet charges stay high, but revenues beat and utilization hit a first-quarter record in more than 15 years.
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent st
Bristol-Myers Squibb: The CAR-T Giant The Market Is Undervaluing
03:20am, Saturday, 02'nd May 2026
Bristol Myers Squibb faces a major patent cliff but is well-equipped with a robust pipeline and significant CAR-T optionality. BMY trades at a discounted 9.4x forward P/E, reflecting patent cliff fear
Pre-Market Stock Futures: Futures are trading mixed as we get ready to finish off another wild week. What a difference a day makes: after a flat-to-down Wednesday, all the major indices exploded highe
Hertz Gains 13% on Uber Robotaxi Deal While Avis Rises 2%: A Tale of Two Rental Car Stocks
02:05pm, Thursday, 30'th Apr 2026
Shares of Hertz (NASDAQ:HTZ) are up 13% on Thursday at roughly $6.35, while Avis Budget Group (NASDAQ:CAR | CAR Price Prediction) stock is only up 2% to around $184.50.
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent
A Wild Short Squeeze on Avis's Stock Takes Another Surprising Turn
05:49pm, Wednesday, 29'th Apr 2026
The rental car company says a hedge-fund firm behind the big swings owes it money because of a niche trading rule.
Avis Budget Group, Inc. (CAR) Q1 2026 Earnings Call Transcript
11:41am, Wednesday, 29'th Apr 2026
Avis Budget Group, Inc. (CAR) Q1 2026 Earnings Call Transcript
Avis Budget (CAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:31am, Wednesday, 29'th Apr 2026
Although the revenue and EPS for Avis Budget (CAR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Stre
